These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26521149)

  • 1. Leptin dose-dependently decreases atherosclerosis by attenuation of hypercholesterolemia and induction of adiponectin.
    Hoffmann A; Ebert T; Klöting N; Dokas J; Jeromin F; Jessnitzer B; Burkhardt R; Fasshauer M; Kralisch S
    Biochim Biophys Acta; 2016 Jan; 1862(1):113-20. PubMed ID: 26521149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin decreases circulating inflammatory IL-6 and MCP-1 in mice.
    Hoffmann A; Ebert T; Klöting N; Kolb M; Gericke M; Jeromin F; Jessnitzer B; Lössner U; Burkhardt R; Stumvoll M; Fasshauer M; Kralisch S
    Biofactors; 2019 Jan; 45(1):43-48. PubMed ID: 30496627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
    Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-/-) mice.
    Silva JC; César FA; de Oliveira EM; Turato WM; Tripodi GL; Castilho G; Machado-Lima A; de Las Heras B; Boscá L; Rabello MM; Hernandes MZ; Pitta MG; Pitta IR; Passarelli M; Rudnicki M; Abdalla DS
    Pharmacol Res; 2016 Feb; 104():49-60. PubMed ID: 26706782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor.
    Lede V; Franke C; Meusel A; Teupser D; Ricken A; Thiery J; Schiller J; Huster D; Schöneberg T; Schulz A
    PLoS One; 2016; 11(12):e0167888. PubMed ID: 28030540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia.
    Mueller MA; Beutner F; Teupser D; Ceglarek U; Thiery J
    Atherosclerosis; 2008 May; 198(1):39-48. PubMed ID: 17980369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.
    Liu C; Schönke M; Zhou E; Li Z; Kooijman S; Boon MR; Larsson M; Wallenius K; Dekker N; Barlind L; Peng XR; Wang Y; Rensen PCN
    Cardiovasc Res; 2022 Jan; 118(2):489-502. PubMed ID: 33693480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models.
    Ohshiro T; Ohtawa M; Nagamitsu T; Matsuda D; Yagyu H; Davis MA; Rudel LL; Ishibashi S; Tomoda H
    J Pharmacol Exp Ther; 2015 Nov; 355(2):299-307. PubMed ID: 26338984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor.
    Hasty AH; Shimano H; Osuga J; Namatame I; Takahashi A; Yahagi N; Perrey S; Iizuka Y; Tamura Y; Amemiya-Kudo M; Yoshikawa T; Okazaki H; Ohashi K; Harada K; Matsuzaka T; Sone H; Gotoda T; Nagai R; Ishibashi S; Yamada N
    J Biol Chem; 2001 Oct; 276(40):37402-8. PubMed ID: 11445560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice.
    Gruen ML; Saraswathi V; Nuotio-Antar AM; Plummer MR; Coenen KR; Hasty AH
    Atherosclerosis; 2006 May; 186(1):54-64. PubMed ID: 16102772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-dependent effect of liver growth factor on atherosclerotic lesions and fatty liver disease in apolipoprotein E knockout mice.
    Surra JC; Guillén N; Barranquero C; Arbonés-Mainar JM; Navarro MA; Gascón S; Arnal C; Godino J; Guzmán MA; Díaz-Gil JJ; Osada J
    Histol Histopathol; 2010 May; 25(5):609-18. PubMed ID: 20238299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond Lipoprotein Receptors: Learning from Receptor Knockouts Mouse Models about New Targets for Reduction of the Atherosclerotic Plaque.
    Trusca VG; Fuior EV; Gafencu AV
    Curr Mol Med; 2015; 15(10):905-31. PubMed ID: 26592248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice.
    Saraswathi V; Gao L; Morrow JD; Chait A; Niswender KD; Hasty AH
    J Nutr; 2007 Jul; 137(7):1776-82. PubMed ID: 17585030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice.
    Que X; Hung MY; Yeang C; Gonen A; Prohaska TA; Sun X; Diehl C; Määttä A; Gaddis DE; Bowden K; Pattison J; MacDonald JG; Ylä-Herttuala S; Mellon PL; Hedrick CC; Ley K; Miller YI; Glass CK; Peterson KL; Binder CJ; Tsimikas S; Witztum JL
    Nature; 2018 Jun; 558(7709):301-306. PubMed ID: 29875409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
    Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
    Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.
    Lin Z; Pan X; Wu F; Ye D; Zhang Y; Wang Y; Jin L; Lian Q; Huang Y; Ding H; Triggle C; Wang K; Li X; Xu A
    Circulation; 2015 May; 131(21):1861-71. PubMed ID: 25794851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,3,4',5-tetrahydroxystilbene-2-O-β-d-glycoside attenuates atherosclerosis in apolipoprotein E-deficient mice: role of reverse cholesterol transport.
    Chen X; Tang K; Peng Y; Xu X
    Can J Physiol Pharmacol; 2018 Jan; 96(1):8-17. PubMed ID: 28863273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.